canertinib dihydrochloride has been researched along with Bone Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Courtney, CL; Dominick, MA; Kim, SN; Walsh, KM; Watkins, JR | 1 |
1 other study(ies) available for canertinib dihydrochloride and Bone Diseases
| Article | Year |
|---|---|
Proliferative bone lesions in rats given anticancer compounds.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Development; Bone Diseases; Bone Marrow; Carbamates; Cell Division; Drug Combinations; Female; Glucuronates; Injections, Intravenous; Male; Pentostatin; Pyrazines; Pyridines; Rats; Rats, Inbred Strains; Trimetrexate | 1991 |